Mar 4, 2021
Before the COVID-19 pandemic, telemedicine largely was underutilized in dermatology. Vincent A. DeLeo, MD, talks to George Han, MD, PhD, about the progression of the reimbursement process and the roadblocks encountered with the expansion of telemedicine. “To me, telemedicine really represents the opportunity to make a dent in access to care ... expanding our access to care, especially in underserved areas in places where a lot of people have barriers, people of lower socioeconomic status, skin of color ... there’s a lot of populations out there where we’re just not able to get the level of coverage and access to dermatologic care that we want,” Dr. Han notes. They also discuss the emergence of direct-to-consumer telemedicine services and how dermatology practices can compete.
Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT107002061.PDF
* * *
Host: Vincent A. DeLeo, MD (University of Southern California, Los Angeles)
Guest: George Han, MD, PhD (Icahn School of Medicine at Mount Sinai, New York)
Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Han reports no conflict of interest.
Show notes by: Allegra Sparta, Melissa Sears
* * *
You can find more of our podcasts at http://www.mdedge.com/podcasts
Email the show: firstname.lastname@example.org